Medtronic (MDT) Net Income towards Common Stockholders (2014 - 2026)

Medtronic has disclosed Net Income towards Common Stockholders across 13 years of filings, most recently posting $1.5 billion for Q3 2026.

• In Q3 2026, Net Income towards Common Stockholders rose 41.36% year-over-year to $1.5 billion; the TTM figure through Jul 2026 stood at $5.3 billion (up 12.39% YoY), while the FY2026 annual figure was $4.8 billion, up 3.09% from the prior year.
• Net Income towards Common Stockholders came in at $1.5 billion for Q3 2026 at Medtronic, up from $1.3 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 billion in Q2 2022 to a low of $436.0 million in Q4 2022.
• Average Net Income towards Common Stockholders over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2023.
• Year-over-year, Net Income towards Common Stockholders tumbled 66.89% in 2022 and soared 108.94% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $436.0 million in 2022, then soared by 108.94% to $911.0 million in 2023, then surged by 40.29% to $1.3 billion in 2024, then rose by 8.14% to $1.4 billion in 2025, then advanced by 7.09% to $1.5 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $1.5 billion in Q3 2026, $1.3 billion in Q2 2026, and $1.2 billion in Q1 2026.